PVD following plasmin but not hyaluronidase: Implications for combination pharmacologic vitreolysis therapy

Retina

Volumn 25, Issue 1, 2005, Pages 38-43

  Wang, Zhi Liang ^a   Zhang, Xi ^a   Xu, Xun ^a   Sun, Xiao Dong ^a   Wang, Fang ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HYALURONIDASE; LAMININ; PLASMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ELECTRORETINOGRAPHY; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; NONHUMAN; RABBIT; SCANNING ELECTRON MICROSCOPY; VITRECTOMY; VITREOUS BODY DETACHMENT;

ANIMALS; BASEMENT MEMBRANE; COMBINED MODALITY THERAPY; ELECTRORETINOGRAPHY; FIBRINOLYTIC AGENTS; FIBRONECTINS; HYALURONOGLUCOSAMINIDASE; IMMUNOHISTOCHEMISTRY; INJECTIONS; LAMININ; MALE; MICROSCOPY, ELECTRON, SCANNING; PLASMIN; RABBITS; VITRECTOMY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 13844251851     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200501000-00005     Document Type: Article

References (18)

1. Sebag J. Pharmacologic vitreolysis. Retina 1998;18:1-3.
2. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849-854.
3. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with Dispase. Retina 1998;8:7-15.
4. Jorge R, Oyamaguchi EK, Cardillo JA, et al. Intravitreal injection of Dispase causes retinal hemorrhages in rabbit and human eyes. Curr Eye Res 2003;26:107-112.
5. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195-198.
6. Harooni M, Mchillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina 1998;18:16-22.
7. Hikichi T, Yanagiya N, Kado M, et al. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999;19:55-58.
8. Sebag J. Pharmacologic vitreolysis brewing? Retina 2002;22:1-3.
9. International Standardization Committee. Standard for clinical electro retinopathy. Arch Ophthalmol 1989;107:816-819.
10. Gandorfer A, Putz E, Welge LU, et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001;85:6-10.
11. Sebag J, Balazs EA. Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 1989;30:1867-1871.
12. Liotta LA, Goldfard RH, Brundage R, et al. Effect of plasminogen activator, plasmin, and collagenous components of basement membrane. Cancer Res 1981;41:4629-4636.
13. Lin WL, Essner E. Immunogold localization of basement membrane molecules in rat retinal capillaries. Cell Mol Biol 1990;36:13-21.
14. Zhang YZ, Lee HZ. Quantitative changes in the glomerular basement membrane components in human membranous nephropathy. J Pathol 1997;183:8-15.
15. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002;240:56-62.
16. Dano K, Andreasen PA, Handen J, et al. Plasminogen activators and cancer. Adv Cancer Res 1985;44:139-166.
17. Baker JR, Yu H, Morrison K, et al. Specificity of the hyaluronate lyase of group-B streptococcus toward unsulphated regions of chondroitin sulphate. Biochem J 1997;327:65-71.
18. Matsumoto B, Blanks JC, Ryan SJ. Topographic variations in the rabbit and primate internal limiting membrane. Invest Ophthalmol Vis Sci 1984;25:71-82.